• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

Covance, Inc.

NYSE:CVD

$46.55 $0.45 (0.98%)

REAL-TIME: Last trade at

Are Covance's Earnings Worse Than They Look?

Golf Clap for Covance

Covance's EPS Meets, Misses on Revs - Analyst Blog

Has Covance Made You Any Real Money?

Maxwell Gets Swiss Funding - Analyst Blog

Neutral on AmerisourceBergen - Analyst Blog

Charges Spoil Covance's 4Q - Analyst Blog

US STOCK FUTURES: HOT STOCKS TO WATCH

US STOCK FUTURES: HOT STOCKS TO WATCH

Covance Shares Slumped: What You Need to Know

Covance Beats Estimates but Has a Dismal Quarter

Covance Earnings Preview

Don't Get Too Worked Up Over ICON's Earnings

Are Shorts Watching Pharmaceutical Product Development?

Covance Earnings Preview

Should You Get Out of ICON Before Next Quarter?

Pharmaceutical Product Development Shares Soared: What You Need to Know

1 Special Stock Pick From an Outside View

Is PAREXEL International Going to Burn You?

Here's How Covance Is Making You So Much Cash

Is ICON the Perfect Stock?

The 15 Most-Watched Life-Sciences Stocks

Covance's CEO Discusses Q2 2011 Results - Earnings Call Transcript

Covance's CEO Discusses Q1 2011 Results - Earnings Call Transcript

Covance's CEO Discusses Q1 2011 Results - Earnings Call Transcript

Contract Research (CROs): On the Brink of Recovery

Happy 2nd birthday, bull market! What now?

Covance CEO Discusses Q4 2010 Earnings Call Transcript

Covance CEO Discusses Q4 2010 Earnings Call Transcript

My 3 Favorite Small Cap Stocks for 2011

CRO Investment Opportunities Remain Compelling

Analyst Calls: AAPL, AMGN, BIIB, BSX, CHK, DVN, EOG, GRMN, PHM, WPO ...

Covance Q3 2010 Earnings Call Transcript

Covance Q3 2010 Earnings Call Transcript

Big Pharma Begins Outsourcing Research and Development

Sanofi Continues to Look Beyond Its Own Walls to Fill the Void From Drugs Going Off-Patent

Covance Enters Into Long-Term R&D Partnership With Sanofi

2nd UPDATE: Sanofi, Covance In 10-Year R&D Outsourcing Deal

Sanofi Showcases Diabetes, Cancer Pipeline; Enters R&D Pact

Analyst Calls: BKS, GE, GSK, ITW, MMM, MXIM, NETL, NOK, RAI, RDC, TYC ...

See More Articles...